Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma.
Saved in:
| Title: | Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma. |
|---|---|
| Authors: | Thongon N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ma F; Division of Rheumatology, Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, MI, USA., Baran N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lockyer P; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Liu J; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jackson C; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Rose A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Furudate K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wildeman B; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Marchesini M; IRCCS Instituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Italy., Marchica V; Department of Medicine and Surgery, University of Parma, Parma, Italy., Storti P; Department of Medicine and Surgery, University of Parma, Parma, Italy., Todaro G; Department of Medicine and Surgery, University of Parma, Parma, Italy., Ganan-Gomez I; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Adema V; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Rodriguez-Sevilla JJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Qing Y; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ha MJ; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Fonseca R; Department of Medicine, Mayo Clinic, Scottsdale, AZ, USA., Stein C; Department of Medicine, Mayo Clinic, Scottsdale, AZ, USA., Class C; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Butler University, Indianapolis, IN, USA., Tan L; Metabolomics Core Facility, Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Attanasio S; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Giuliani N; Department of Medicine and Surgery, University of Parma, Parma, Italy., Berrios Nolasco D; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Santoni A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Cerchione C; IRCCS Instituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Italy., Bueso-Ramos C; Department of Hemopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lorenzi P; Metabolomics Core Facility, Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Takahashi K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Manasanch E; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sammarelli G; Department of Medicine and Surgery, University of Parma, Parma, Italy., Kanagal-Shamanna R; Department of Hemopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Viale A; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chesi M; Department of Medicine, Mayo Clinic, Scottsdale, AZ, USA., Colla S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. scolla@mdanderson.org. |
| Source: | Nature communications [Nat Commun] 2024 Feb 08; Vol. 15 (1), pp. 1203. Date of Electronic Publication: 2024 Feb 08. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2041-1723 |
|---|---|
| DOI: | 10.1038/s41467-024-45350-8 |
